InMed Pharmaceuticals

MTRI on Nasdaq. Market value $102m.

Watch this stockFree. We tell you when something changes.

Should I look at this?

We have not checked this company yet

This is not advice.

Compare with another stock

Who owns it

We don't have fund holdings for this stock yet.

Big holders and activists

8 investors own more than 5%.

  • Vivo Opportunity Fund Holdings, L.P.
    Passive investor
    at least 21.7%
    (filed with 3 related holders)
    Since 19 May 2026
    What they said

    On May 19, 2026, the Issuer, Indigo Merger Sub Corp., a Delaware corporation and a wholly owned subsidiary of the Issuer (the "First Merger Sub"), Indigo Merger Sub II, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Issuer (the "Second Merger Sub"…

    Read the filing
  • at least 20.0%
    (filed with 3 related holders)
    Since 6 November 2026
    What they said

    The Reporting Persons own 19.99% of the Company in the aggregate, based upon the Company's aggregate outstanding shares as of November 6, 2026. The Reporting Persons' securities include 10,555,507 shares of Common Stock directly held by Fund II, and exclude (i) 4,013,000 shares…

    Read the filing
  • at least 17.2%−6.9 pts
    (filed with 1 related holder)
    Since 30 September 2026
  • YA II PN, Ltd.
    Passive investor
    at least 10.0%
    (filed with 7 related holders)
    Since 13 December 2024
  • SABBY MANAGEMENT, LLC
    Passive investor
    at least 9.9%+5.0 pts
    (filed with 2 related holders)
    Since 31 December 2025
  • Deep Track Capital, LP
    Passive investor
    at least 5.6%
    (filed with 3 related holders)
    Since 6 November 2026
  • Commodore Capital LP
    Passive investor
    at least 5.6%
    (filed with 3 related holders)
    Since 6 November 2026
  • Ikarian Capital, LLC
    Passive investor
    at least 4.2%
    (filed with 1 related holder)
    Since 30 June 2026
  • Sold down below 5%
    Since 30 September 2026
  • AdvisorShares Trust
    Passive investor
    Sold down below 5%
    Since 31 March 2025

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

No insider bought or sold on the open market in the last 12 months.

From Form 4 filings: insiders must report trades in their own company's shares within two days.

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from
Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.